autophagy

I04 Reduction of glutamate dehydrogenase increases autophagy and ameliorate motility and survival in a drosophila model for huntington’s disease
Paola Bellosta, Stefania Santarelli, Chiara Londero

Journal of Neurology, Neurosurgery & Psychiatry Sep 2021, 92 (Suppl 1) A49; DOI: 10.1136/jnnp-2021-EHDN.118
A14 Retinal and striatal profiling of the r6/1 mouse model of huntington’s disease
Luis M Valor, Andrea Gallardo-Orihuela, Fátima Cano-Cano, Laura Gómez-Jaramillo, Irati Hervás-Corpión, Francisco Martín-Loro, Pedro de la Villa, Ana I Arroba

Journal of Neurology, Neurosurgery & Psychiatry Sep 2021, 92 (Suppl 1) A6; DOI: 10.1136/jnnp-2021-EHDN.13
A17 Targeting mitophagy in huntington’s disease patients’ fibroblasts
Ivan Šonský, Nikol Volfová, Marie Rodinová, Petr Vodička, Jiří Klempíř, Hana Hansikova

Journal of Neurology, Neurosurgery & Psychiatry Sep 2021, 92 (Suppl 1) A7; DOI: 10.1136/jnnp-2021-EHDN.16
A29 Deciphering how fat metabolism and ampk impact autophagy in Huntington’s disease
Andrea del Valle Carranza, Mar Collado-Pérez, Rafael Vázquez-Manrique

Journal of Neurology, Neurosurgery & Psychiatry Sep 2022, 93 (Suppl 1) A10-A11; DOI: 10.1136/jnnp-2022-ehdn.29
A36 Neuropathological function of the TANK1-binding kinase 1 (TBK1) in mouse models of Huntington’s disease
Ibrahim Raya, Yasmin Douahem, David Brenner, Rüstem Yilmaz, Riccardo Cristofani, Angelo Poletti, Vittorio Maglione, Jochen Weishaupt, Rosanna Parlato

Journal of Neurology, Neurosurgery & Psychiatry Sep 2022, 93 (Suppl 1) A13; DOI: 10.1136/jnnp-2022-ehdn.36
I15 Reduction of glutamate dehydrogenase induces autophagy via tor inhibition and AMPK activation in a drosophila model for Huntington’s disease
Stefania Santarelli, Carlotta Candelaresi, Leonardo Todeschini, Chiara Londero, Paola Bellosta

Journal of Neurology, Neurosurgery & Psychiatry Sep 2022, 93 (Suppl 1) A89-A90; DOI: 10.1136/jnnp-2022-ehdn.241
I18 Treatment with THI, an inhibitor of sphingosine-1-phosphate lyase (SGPL1), modulates glycosphingolipid metabolism and results therapeutically effective in a mouse model of Huntington’s disease
Giuseppe Pepe, Luca Capocci, Federico Marracino, Natalia Realini, Pamela Scarselli, Clotilde Di Cicco, Andrea Armirotti, Rosanna Parlato, Alba Di Pardo, Vittorio Maglione

Journal of Neurology, Neurosurgery & Psychiatry Sep 2022, 93 (Suppl 1) A91; DOI: 10.1136/jnnp-2022-ehdn.244
I23 Pridopidine exerts neuroprotective effects via activation of the sigma-1 receptor
Michal Geva, Chiara Scaramuzzino, Sophie Lenoir, Romane A Lahaye, Shao-Ming Wang, Hsiang-en Wu, Noga Gershoni-Emek, Frédéric Saudou, Tsung-Ping Su, Michael R Hayden

Journal of Neurology, Neurosurgery & Psychiatry Sep 2022, 93 (Suppl 1) A92-A93; DOI: 10.1136/jnnp-2022-ehdn.249
A27 Targeting glutamine dehydrogenase activity to induce autophagy and ameliorate neuronal degeneration; studies using a drosophila model for huntington’ disease
Paola Bellosta, Chiara Paiardi, Maria E Pasini

Journal of Neurology, Neurosurgery & Psychiatry Sep 2018, 89 (Suppl 1) A9-A10; DOI: 10.1136/jnnp-2018-EHDN.25
M12 A769662 Leads to AMPK Activation, Induces Autophagy and has Beneficial Effects IN HD Cells
C Walter, S Metzger, A Weiss, O Riess, H Phuc Nguyen

Journal of Neurology, Neurosurgery & Psychiatry Sep 2014, 85 (Suppl 1) A98; DOI: 10.1136/jnnp-2014-309032.284

Main menu

autophagy

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

autophagy

Pages